Search company, investor...
Sanovas company logo



Unattributed | Alive

Total Raised


Last Raised

$990K | 7 yrs ago

About Sanovas

Sanovas is a life science technology company developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies for unmet clinical needs. Sanovas' microsurgical technology platforms are designed to give surgeons the ability to access and visualize previously inaccessible areas of the body; enabling them to diagnose, treat and deliver drug and immune therapies to small diameter anatomy in entirely new ways. Privately held, Sanovas was founded by the pioneers in minimally invasive surgery. The company has two patents issued and more than fifty multi-national patents pending.

Headquarters Location

2597 Kerner Blvd

San Rafael, California, 94901,

United States


Missing: Sanovas's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Sanovas's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Sanovas

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sanovas is included in 3 Expert Collections, including Medical Devices.


Medical Devices

11,721 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

2,623 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Health IT

7,901 items

Sanovas Patents

Sanovas has filed 57 patents.

The 3 most popular patent topics include:

  • Medical equipment
  • Endoscopy
  • Ophthalmology
patents chart

Application Date

Grant Date


Related Topics




Medical equipment, Endoscopy, Surgical instruments, Medical imaging, Surgical removal procedures


Application Date


Grant Date



Related Topics

Medical equipment, Endoscopy, Surgical instruments, Medical imaging, Surgical removal procedures



Latest Sanovas News

Former CEO of Bay Area medical device startup sentenced to 11 years in prison

Nov 9, 2020

The former CEO of a Marin County biomedical device company was sentenced by a federal judge Thursday to more than 11 years in prison for systematically siphoning money from the company he ran. Lawrence J. Garrens, formerly CEO of Sanovas Inc., was charged with five counts of wire fraud, one count of engaging in monetary transactions in criminally derived property, three counts of making false statements to a government agency, one count of contempt of court, one count of witness tampering and o

Sanovas Frequently Asked Questions (FAQ)

  • Where is Sanovas's headquarters?

    Sanovas's headquarters is located at 2597 Kerner Blvd, San Rafael.

  • What is Sanovas's latest funding round?

    Sanovas's latest funding round is Unattributed.

  • How much did Sanovas raise?

    Sanovas raised a total of $39.81M.

  • Who are the investors of Sanovas?

    Investors of Sanovas include Qualifying Therapeutic Discovery Project.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.